Pharmaceuticals
Biopharmaceutical
Unitedstates
Treatments
Commercializing
M&A Advisory
Lazard
Full Credential Description
Savient Pharmaceuticals. United States. Announced Date 01/02/2011. Closed Date 01/02/2011. Deal value: $230m. Convertible senior notes. Industry: Savient Pharmaceuticals was a biopharmaceutical company focused on developing and commercializing treatments for rare diseases.